Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

ONCOC4 INC

Group Recipients By:

Issue Date FY Summary


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Award Number	Award Title	Award Code	Budget Year	OPDIV	Action Date	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	ONCOC4 INC	9640 MEDICAL CENTER DR	ROCKVILLE	MD	20850-3368	MONTGOMERY	USA	R44CA250824	First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy	000	3	NIH	12/21/2023	$0
															Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $1,000,000 )
2022	2022	ONCOC4, INC.	9640 MEDICAL CENTER DR	ROCKVILLE	MD	20850-3368	MONTGOMERY	USA	R44CA250824	First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy	000	3	NIH	4/4/2022	$1,000,000
															Subtotal = $1,000,000

Issue Date FY: 2021 ( Subtotal = $1,000,000 )
2021	2021	ONCOC4, INC.	9640 MEDICAL CENTER DR	ROCKVILLE	MD	20850-3368	MONTGOMERY	USA	R44CA250824	First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy	002	2	NIH	8/27/2021	$0
2021	2021	ONCOC4, INC.	9640 MEDICAL CENTER DR	ROCKVILLE	MD	20850-3368	MONTGOMERY	USA	R44CA250824	First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy	001	2	NIH	4/1/2021	$1,000,000
															Subtotal = $1,000,000

Grand Total All Awards = $2,000,000

Top